120 related articles for article (PubMed ID: 8569232)
1. Acute hemodynamic effects of ciprokiren, a novel renin inhibitor, in sodium-depleted dogs.
Clozel JP; Véniant M; Sprecher U; Fischli W
J Cardiovasc Pharmacol; 1995 Oct; 26(4):674-7. PubMed ID: 8569232
[TBL] [Abstract][Full Text] [Related]
2. Ciprokiren (Ro 44-9375). A renin inhibitor with increasing effects on chronic treatment.
Fischli W; Clozel JP; Breu V; Buchmann S; Mathews S; Stadler H; Vieira E; Wostl W
Hypertension; 1994 Aug; 24(2):163-9. PubMed ID: 8039839
[TBL] [Abstract][Full Text] [Related]
3. Effects of renin inhibitor A-72517 on hemodynamics and cardiac function in sodium-depleted dogs.
Wessale JL; Kleinert HD; Calzadilla SV; Kovar PJ; Rosenberg SH
Am J Hypertens; 1993 Jun; 6(6 Pt 1):514-21. PubMed ID: 8343235
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin pathway is involved in acute hemodynamic effects of enalaprilat in dogs with heart failure.
Barbe F; Su JB; Guyene TT; Crozatier B; Ménard J; Hittinger L
Am J Physiol; 1996 Jun; 270(6 Pt 2):H1985-92. PubMed ID: 8764248
[TBL] [Abstract][Full Text] [Related]
5. Renal vascular and biochemical responses to systemic renin inhibition in dogs at low renal perfusion pressure.
Clozel JP; Véniant MM; Qiu C; Sprecher U; Wolfgang R; Fischli W
J Cardiovasc Pharmacol; 1999 Nov; 34(5):674-82. PubMed ID: 10547083
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects and hemodynamic mechanism of action of the novel, nonpeptidic renin inhibitor A-74273 in dogs.
Wessale JL; Calzadilla SV; Boyd SA; Baker WR; Stein HH; Kovar PJ; Barlow J; Klinghofer V; Mantei R; Kleinert HD
J Cardiovasc Pharmacol; 1993 Oct; 22(4):644-52. PubMed ID: 7505369
[TBL] [Abstract][Full Text] [Related]
7. Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
Su J; Barbe F; Houël R; Guyene TT; Crozatier B; Hittinger L
Basic Res Cardiol; 1999 Apr; 94(2):128-35. PubMed ID: 10326661
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikiren.
van Kats JP; Sassen LM; Danser AH; Polak MP; Soei LK; Derkx FH; Schalekamp MA; Verdouw PD
Br J Pharmacol; 1996 Mar; 117(5):891-901. PubMed ID: 8851507
[TBL] [Abstract][Full Text] [Related]
9. Ro 42-5892 is a potent orally active renin inhibitor in primates.
Fischli W; Clozel JP; el Amrani K; Wostl W; Neidhart W; Stadler H; Branca Q
Hypertension; 1991 Jul; 18(1):22-31. PubMed ID: 1830563
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure.
Sweet CS; Ludden CT; Frederick CM; Ribeiro LG
Am J Med; 1984 Aug; 77(2A):7-12. PubMed ID: 6089558
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of the blood pressure lowering action of renin inhibition and comparison with angiotensin converting enzyme inhibition.
Blaine EH
J Hypertens Suppl; 1989 Apr; 7(2):S47-9. PubMed ID: 2666614
[TBL] [Abstract][Full Text] [Related]
12. Major role of the renin angiotensin system in the neointima formation after vascular injury in guinea pigs.
Clozel JP; Hess P; Schietinger K; Breu V; Fischli W; Baumgartner HR
Life Sci; 1994; 54(6):PL87-92. PubMed ID: 8295484
[TBL] [Abstract][Full Text] [Related]
13. Effects of renin-angiotensin system blockade in guinea pigs.
Véniant M; Clozel JP; Hess P; Fischli W
Hypertension; 1992 Mar; 19(3):255-62. PubMed ID: 1532164
[TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.
Liang CS; Gavras H; Hood WB
J Clin Invest; 1978 Apr; 61(4):874-83. PubMed ID: 659580
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
Laubie M; Schiavi P; Vincent M; Schmitt H
J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
[TBL] [Abstract][Full Text] [Related]
16. Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure.
Sweet CS; Ludden CT; Frederick CM; Bush LR; Ribeiro LG
J Cardiovasc Pharmacol; 1984; 6(6):1067-75. PubMed ID: 6084762
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of the new angiotensin-converting-enzyme inhibitor, cilazapril, in anesthetized and conscious dogs.
Holck M; Fischli W; Hefti F; Gerold M
J Cardiovasc Pharmacol; 1986; 8(1):99-108. PubMed ID: 2419701
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
[TBL] [Abstract][Full Text] [Related]
19. Angiotensinergic versus nonangiotensinergic hemodynamic effects of converting enzyme inhibition in patients with chronic heart failure. Assessment by acute renin and converting enzyme inhibition.
Kiowski W; Beermann J; Rickenbacher P; Haemmerli R; Thomas M; Burkart F; Meinertz T
Circulation; 1994 Dec; 90(6):2748-56. PubMed ID: 7994817
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]